|
Press Releases |
|
![](/images/company/SinoBio.jpg) |
|
Thursday, May 28, 2020 |
|
Sino Biopharmaceutical Announces 2020 First Quarterly Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2020 ("the review period"). more info >> |
|
Tuesday, May 26, 2020 |
|
中国生物制药与康方生物共同开发派安普利新药上市申请获国家药品监督管理局受理 |
中国领先的创新研发驱动型医药集团 — 中国生物制药有限公司(股份代号:1177)宣布,与致力研究、开发、生产及商业化全球病人可负担的创新抗体新药的生物制药公司康方生物科技(开曼)有限公司(「康方生物」;股份代号:9926) more info >> |
|
中國生物製藥與康方生物共同開發派安普利新藥上市申請獲國家藥品監督管理局受理 |
中國領先的創新研發驅動型醫藥集團 — 中國生物製藥有限公司(股份代號:1177)宣佈,與致力研究、開發、生產及商業化全球病人可負擔的創新抗體新藥的生物製藥公司康方生物科技(開曼)有限公司(「康方生物」;股份代號:9926) more info >> |
|
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration |
Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the new drug application of the anti PD-1 monoclonal antibody drug more info >> |
|
Tuesday, May 19, 2020 |
|
中国生物制药与康方生物共同开发派安普利单抗联合安罗替尼一线治疗晚期肝癌的临床试验数据获ASCO年会接受呈列 |
中国领先的创新研发驱动型医药集团 — 中国生物制药有限公司(股份代号:1177)宣布,与康方生物科技(开曼)有限公司(「康方生物」;股份代号:9926),共同开发及商业化的派安普利单抗(AK105,PD-1单抗)联合安罗替尼一线治疗晚期肝细胞癌的临床疗效和安全性二期研究数据摘要,获即将召开的2020年美国临床肿瘤学会(ASCO)年会接受以海报形式呈列。 more info >> |
|
中國生物製藥與康方生物共同開發派安普利單抗聯合安羅替尼一線治療晚期肝癌的臨床試驗數據獲ASCO年會接受呈列 |
中國領先的創新研發驅動型醫藥集團 — 中國生物製藥有限公司(股份代號:1177)宣佈,與康方生物科技(開曼)有限公司(「康方生物」;股份代號:9926),共同開發及商業化的派安普利單抗(AK105,PD-1單抗)聯合安羅替尼一線治療晚期肝細胞癌的臨床療效和安全性二期研究數據摘要,獲即將召開的2020年美國臨床腫瘤學會(ASCO)年會接受以海報形式呈列。 more info >> |
|
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting |
Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the abstracts on phase II study on clinical efficacy and safety of Penpulimab more info >> |
|
Monday, March 30, 2020 |
|
中国生物制药公布2019年年度业绩 |
中国领先的创新研发驱动型医药集团—中国生物制药有限公司(「中国生物制药」或「公司」,连同附属公司统称「集团」)(股票编号:1177)公布截至2019年12月31日止年度(「年度」)之财务业绩。 more info >> |
|
中國生物製藥公佈2019年年度業績 |
中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司(「中國生物製藥」或「公司」,連同附屬公司統稱「集團」)(股票編號:1177)公佈截至2019年12月31日止年度(「年度」)之財務業績。 more info >> |
|
Sino Biopharm Announces 2019 Annual Results |
Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX: 1177), a leading, innovative research and development driven pharmaceutical conglomerate in the PRC, has announced its financial results for the year ended 31 December 2019 ("the year"). more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
NEC technology reliably measures sea levels from a greater distance
Jul 16, 2024 17:45 JST
|
|
|
全球发展数字经济直播访谈会正式举办 外方来华参会高级别代表走进东方甄选直播间
Jul 16, 2024 15:08 HKT/SGT
|
|
|
巨星传奇(6683.HK)解禁后首个交易日: 收盘报10.4港元 升幅达2.97%
Jul 16, 2024 14:58 HKT/SGT
|
|
|
全球發展數字經濟直播訪談會正式舉辦 外方來華參會高級別代表走進東方甄選直播間
Jul 16, 2024 14:25 HKT/SGT
|
|
|
Fujitsu and Cohere launch strategic partnership and joint development to provide generative AI for enterprises
Jul 16, 2024 15:13 JST
|
|
|
エーザイ、ホスラブコナゾールのアジア・オセアニアにおけるライセンス契約を佐藤製薬と締結
Jul 16, 2024 13:00: JST
|
|
|
富士通とCohere、企業向け生成AIの提供に向けた戦略的パートナーシップを締結し、共同開発を開始
Jul 16, 2024 13:00: JST
|
|
|
卓悅集團旗下卓悅奧特萊斯Beauty Outlet開幕
Jul 15, 2024 22:58 HKT/SGT
|
|
|
Malaysian Aviation Commission Handpicks Indonesia's TransNusa Airlines as One of the Two Foreign Airlines to Operate from its distinguished Subang Airport
Jul 15, 2024 22:00: JST
|
|
|
Malaysian Aviation Commission Handpicks Indonesia's TransNusa Airlines as One of the Two Foreign Airlines to Operate from its distinguished Subang Airport
Jul 15, 2024 21:00 HKT/SGT
|
|
|
卓悦集团旗下卓悦奥特莱斯Beauty Outlet开幕
Jul 15, 2024 20:56 HKT/SGT
|
|
|
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025
Jul 15, 2024 19:00 HKT/SGT
|
|
|
Telin and BW Digital to enhance DC-to-DC connectivity with new Indonesia - Singapore cable
Jul 15, 2024 17:50 HKT/SGT
|
|
|
Legend Capital's Portfolio Company Singfilm Solar Achieves Breakthrough in Perovskite Solar Cell Efficiency
Jul 15, 2024 17:10 HKT/SGT
|
|
|
NEC transfers a portion of its shares in NEC Capital Solutions, an equity method affiliate
Jul 15, 2024 16:58 JST
|
|
|
|
More News >> |
|
|
|
|
|